Glucose‐Dependent Insulinotropic Polypeptide and Glucagon After Weight Loss Induced by Diet or Bariatric Surgery
Obesity · 2025
DOI: 10.1002/oby.70049 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Obesity, 2025. Verfasst von Amanda Finn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Diet, Reducing, Gastric Inhibitory Polypeptide, Glucagon, Obesity, Morbid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU).
Abstract (Originalsprache)
Objective
This study compared the effects of a very low‐energy diet (VLED), alone or combined with sleeve gastrectomy (SG) or Roux‐en‐Y gastric bypass (RYGB), on glucose‐dependent insulinotropic polypeptide (GIP) and glucagon concentrations, hormones likely to play a role in weight loss maintenance.
Methods
Participants with severe obesity underwent 10 weeks of VLED alone ( n = 15) or combined with SG ( n = 15) or RYGB ( n = 14). Plasma concentrations of glucagon and GIP (fasting and the first 60 min of a meal), insulin sensitivity, respiratory quotient, and resting energy expenditure (REE) were measured at pre‐ and post‐intervention. Differences in hormone concentrations between groups at follow‐up and associations between hormones and metabolic outcomes were evaluated.
Results
Fasting glucagon concentrations were higher, while postprandial GIP concentrations were lower, after RYGB compared to SG. An increase in postprandial glucagon was associated with a decrease in Matsuda index in the RYGB group and with an increase in REE in all groups. An increase in fasting GIP was correlated with an increase in HOMA‐IR.
Conclusions
RYGB was associated with lower postprandial GIP and greater glucagon concentrations compared with other groups. These hormonal changes are likely to impact REE, as well as insulin sensitivity, potentially modulating the likelihood of weight loss maintenance. Trial Registration: ClinicalTrials.gov identifier NCT04051190.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
ORCID-Profile: Amanda Finn, Yenni Cedillo, Marthe Aukan, Catia Martins
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU)
- W.T. Garvey Endowed Scholarship
- Nutrition Obesity Research Center, University of Alabama at Birmingham
- Diabetes Research Center, University of Alabama at Birmingham
- National Heart, Lung, and Blood Institute
- Respiratory Health Association
Zitieren
APA
Finn, A., Cedillo, Y., Aukan, M., Gower, B., & Martins, C. (2025). Glucose‐Dependent Insulinotropic Polypeptide and Glucagon After Weight Loss Induced by Diet or Bariatric Surgery. Obesity. https://doi.org/10.1002/oby.70049
Vancouver
Finn A, Cedillo Y, Aukan M, Gower B, Martins C. Glucose‐Dependent Insulinotropic Polypeptide and Glucagon After Weight Loss Induced by Diet or Bariatric Surgery. Obesity. 2025. doi:10.1002/oby.70049
BibTeX
@article{Finn2025,
author = {Finn, Amanda and Cedillo, Yenni and Aukan, Marthe and Gower, Barbara and Martins, Catia},
title = {Glucose‐Dependent Insulinotropic Polypeptide and Glucagon After Weight Loss Induced by Diet or Bariatric Surgery},
journal = {Obesity},
year = {2025},
doi = {10.1002/oby.70049}
}
EUVIMED